A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1986
11/25/1986	US4624924 Novel collagenase "discolysin" and production method thereof
11/25/1986	US4624921 Cultures, fusion
11/25/1986	US4624804 Process of preparing relaxin from milk
11/25/1986	CA1214459A1 Conjugates of anticoagulant and protein
11/25/1986	CA1214458A1 Neocarzinostatin complexes, a method for producing the same, and an antitumor agent containing said complexes as an active component
11/25/1986	CA1214413A1 Antibiotic a51568 factors a and b
11/25/1986	CA1214411A1 Process for the preparation of immune interferon
11/20/1986	WO1986006745A1 MOLECULAR CLONING OF cDNA FOR HUMAN FACTOR VIIIR (VON WILLEBRAND FACTOR)
11/20/1986	WO1986006744A1 A cDNA MOLECULE CODING FOR THE EXPRESSION OF AN INTERFERON alpha TYPE POLYPEPTIDE, A BACTERIAL OR CELLULAR HOST TRANSFORMED WITH SUCH MOLECULE AND A POLYPEPTIDE SHOWING INTERFERON ACTIVITY PREPARED BY SUCH HOST
11/20/1986	WO1986006635A1 Oral vaccines
11/20/1986	EP0202005A1 Diagnostic method for detection of neural crest disease
11/20/1986	EP0201823A2 Novel intermediates for the production of pharmaceuticals
11/20/1986	EP0201743A2 Dipeptide derivatives of fatty acids, process for preparing them, pharmaceutical composition and use
11/20/1986	EP0201741A2 Dipeptide derivatives, processes for preparing them, pharmaceutical composition and use
11/20/1986	EP0201716A2 Expression of immunologically reactive viral proteins
11/20/1986	EP0201618A1 Process for the polymerization of hemoglobin utilizing cross-linking agents
11/20/1986	EP0201559A1 A method for preventing or alleviating skin irritation using a formulation containing superoxide dismutase
11/20/1986	EP0201520A1 Monoclonal antibodies and their use
11/20/1986	EP0201519A1 Monoclonal antibodies and their use
11/18/1986	US4623733 Antimicrobial peptide
11/18/1986	US4623717 Pasteurized therapeutically active protein compositions
11/18/1986	US4623716 Process for the preparation and purification of peptides
11/18/1986	US4623715 Antidepressants
11/18/1986	US4623714 Antidiabetic
11/18/1986	US4623640 Peptides
11/18/1986	US4623639 Peptide derivatives
11/18/1986	US4623541 Production of purified porcine immunoglobulins
11/18/1986	CA1214129A1 Mammalian cell line producing growth hormones, preferably human and vectors used to obtain same
11/18/1986	CA1214124A1 Monoclonal antibody covalently linked to the toxin ricin
11/18/1986	CA1214102A1 Pharmaceutical preparation containing purified fibronectin
11/12/1986	EP0201420A1 2-(2-Acetamido-2-deoxy-3-O-D-glucopyranosyl)-alkanoyl-aminoacyl-nor leucin glycopeptides or derivatives of these glycopeptides, and immunoadjuvant compositions containing them
11/12/1986	EP0201260A2 GnRH antagonists
11/12/1986	EP0201251A2 Novel glycopeptide derivatives
11/12/1986	EP0201219A1 Growth-promoting compositions
11/12/1986	EP0201004A2 Polyvalent hyperimmunoglobulin preparation
11/12/1986	EP0200986A1 Recombinant human interleukin-1
11/12/1986	EP0200966A2 Method of stabilizing urokinase precursor and dry preparation containing said precursor
11/12/1986	EP0200909A2 Preparation of protein G and/or fragments thereof
11/12/1986	EP0200757A1 Promotion of wound healing with human epidermal growth factor prepared from recombinant dna.
11/12/1986	EP0200745A1 Monoclonal antibodies and their use
11/12/1986	EP0035038B1 Peripheral circulation failure-curing agent
11/12/1986	CN86100617A Process for the isolation of chicken egg white cystatin, antiviral agents containing it and its use as viral protease inhibitor
11/11/1986	US4622388 Polypeptides
11/11/1986	US4622387 8-methionine calcitonin
11/11/1986	US4622386 [1,7-di-alanine]calcitonin
11/11/1986	US4622312 Growth hormone releasing factor analogs
11/11/1986	US4622218 Testicular-specific drug delivery
11/06/1986	WO1986006490A1 Method for augmenting immune response
11/06/1986	WO1986006414A1 Synthetic antigens for the detection of aids-related disease
11/06/1986	WO1986006413A1 Diagnostic reagents based on unique sequences within the variable region of the t cell receptor and uses thereof
11/06/1986	WO1986006406A1 Vectors for the expression and secretion of hirudin by transformed yeasts
11/06/1986	WO1986006385A1 Method for purifying interferon and composition of matter produced thereby
11/06/1986	WO1986006381A1 Pharmacologically active peptides
11/06/1986	WO1986006280A1 Use of tumor necrosis factor as a weight regulator
11/06/1986	WO1986006279A1 Acute phase protein modulating endotoxic activity of lipopolysaccharides, compositions and methods
11/06/1986	WO1986004217A3 Protein hydrolysates, production process and drugs containing th em
11/05/1986	EP0200655A1 Expression and secretion vectors for hirudine by way of transformed yeasts
11/05/1986	EP0200590A1 Method for the microbiological synthesis of human serum albumin
11/05/1986	EP0200512A2 Peptides and their use in therapy
11/05/1986	EP0200467A2 Superoxide dismutase combined with a poly(alkylene oxide)
11/05/1986	EP0200464A2 A tumor associated antigen
11/05/1986	EP0200451A1 Protease resistant urokinase composition, its production and use
11/05/1986	EP0200421A2 Expression of factor VII activity in mammalian cells
11/05/1986	EP0200417A2 Production of protein
11/05/1986	EP0200214A2 Treatment of parasitic diseases
11/05/1986	EP0200188A2 Compounds having somatostatin-like activity useful for the manufacture of local anti-inflammatory compositions
11/05/1986	EP0200090A2 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
11/05/1986	EP0199992A1 Adsorption-resistant peptide composition and use of benzalkonium or benzethonium chloride in the preparation thereof
11/05/1986	EP0199769A1 Novel polypeptides having growth factor activity and nucleic acid sequences encoding the polypeptides
11/05/1986	EP0199756A1 Monoclonal antibodies and their use
11/05/1986	EP0199755A1 Monoclonal antibodies and their use
11/05/1986	EP0199754A1 Monoclonal antibodies and their use
11/05/1986	EP0199753A1 Monoclonal antibodies and their use
11/05/1986	EP0093436B1 Process for preparing permanent animal and human cell lines, and their use
11/05/1986	CN86101066A Process for the production of new trifluoromethyl ketone substituted peptide derivatives
11/04/1986	US4621135 Oligo peptides having thymic humoral acitivity
11/04/1986	US4621074 Method of treating smoking withdrawal syndrome
11/04/1986	US4621073 Cyclic peptides having somatostatin activity
11/04/1986	US4621054 Biologically active substance, process for preparing the substance and immunoactive composition
11/04/1986	US4621053 Process for the production of human peptide hormones
11/04/1986	US4621052 Process for the production of human epidermal growth factor
11/04/1986	US4621051 Process for the production of human multiplication-stimulating activity
11/04/1986	US4621050 Process for the production of human colony-stimulating factor
11/04/1986	US4620977 Treatment methods, particularly for psychoactive drug dependence
11/04/1986	US4620972 Method of inhibiting the growth of malignant tumor cells
11/04/1986	US4620327 Use in biocompatible, biodegradable masses
11/04/1986	CA1213583A1 Synergistine derivatives, their preparation, and pharmaceuticals containing such
11/04/1986	CA1213543A1 Enzyme-containing digestive aid compositions
11/04/1986	CA1213539A2 Bacterial polypeptide expression employing tryptophan promoter-operator
11/04/1986	CA1213536A1 Monoclonal antibody, method of producing the same and use thereof
11/04/1986	CA1213520A1 Hydrophilic biopolymeric copolyelectrolytes, and biodegradable dressings comprising same
10/1986
10/29/1986	EP0199586A2 Tumour-associated antigen
10/29/1986	EP0199574A2 Human tissue plasminogen activator mutants, methods and intermediates therefor, and compositions using such mutants
10/29/1986	EP0199568A2 Method for purifying interferon and composition of matter produced thereby
10/29/1986	EP0199479A2 Ozone decontamination of blood and blood products
10/29/1986	EP0199451A2 Therapeutic nucleosides
10/29/1986	EP0199438A1 HTLV III Polypeptides
10/29/1986	EP0199379A2 Pharmacologically active tripeptides and process for their synthesis
10/29/1986	EP0199331A1 Pharmacologically active peptides
10/29/1986	EP0199302A2 Contraception in dogs with luteinizing hormone releasing hormone antagonists

1 ... 3097 3098 3099 3100 3101 3102 3103 3104 3105 3106 3107 3108 3109 3110 3111 3112 3113 3114 3115 3116 3117 ... 3163